Quote | Neoleukin Therapeutics Inc. (NYSE:NLTX)
Last: | $ |
---|---|
Change Percent: | 0.67% |
Open: | $11.80 |
Close: | $11.97 |
High: | $12.40 |
Low: | $11.67 |
Volume: | 263,672 |
Last Trade Date Time: | 02/12/2020 04:42:54 pm |
News | Neoleukin Therapeutics Inc. (NYSE:NLTX)
2023-12-15 04:18:07 ET More on Neoleukin Therapeutics Financial information for Neoleukin Therapeutics For further details see: Neoleukin Therapeutics announces 1-for-4 reverse stock split
SEATTLE, Dec. 14, 2023 (GLOBE NEWSWIRE) -- Neoleukin Therapeutics, Inc., “Neoleukin” or the “Company” (NASDAQ:NLTX), a biopharmaceutical company that has designed de novo protein therapeutics utilizing sophisticated computational methods, today announced that its B...
Message Board Posts | Neoleukin Therapeutics Inc. (NYSE:NLTX)
Subject | By | Source | When |
---|---|---|---|
$NLTX Neoleukin Therapeutics Inc | mick | investorshub | 04/30/2023 9:18:28 PM |
52WK RANGE 0.38 - 1.56 | mick | investorshub | 04/15/2023 3:33:30 PM |
$NLTX Neoleukin Therapeutics Inc | mick | investorshub | 04/15/2023 3:32:51 PM |
znewcar1: $NLTX 35% v10,8M c.72 f42,594M H.7595 ML.49 gapNgo | znewcar1 | investorshangout | 03/09/2023 11:16:35 PM |
$NLTX Neoleukin Therapeutics Inc | mick | investorshub | 02/27/2023 12:31:05 AM |
News, Short Squeeze, Breakout and More Instantly...
Neoleukin Therapeutics Inc. Company Name:
NLTX Stock Symbol:
NYSE Market:
SEATTLE, Dec. 14, 2023 (GLOBE NEWSWIRE) -- Neoleukin Therapeutics, Inc., “Neoleukin” or the “Company” (NASDAQ:NLTX), a biopharmaceutical company that has designed de novo protein therapeutics utilizing sophisticated computational methods, today announced that its B...
INVO BioScience Inc. (INVO) is expected to report for Q3 2023 HIVE Blockchain Technologies Ltd (HIVE) is expected to report $-0.13 for Q2 2024 BioNexus Gene Lab Corp (BGLC) is expected to report for Q1 2024 Adhera Therapeutics Inc (ATRX) is expected to report for Q1 2024 Altus Pow...
Neoleukin Therapeutics Inc. (NLTX) is expected to report $-0.8 for Q3 2023